Single-cell RNA sequencing in juvenile idiopathic arthritis
返回论文页
Review article|更新时间:2024-02-04
|
Single-cell RNA sequencing in juvenile idiopathic arthritis
Single-cell RNA sequencing in juvenile idiopathic arthritis
Genes & Diseases2024年11卷第2期
作者机构:
1. Department of Rheumatology and Immunology, Children’s Hospital of Chongqing Medical University,Chongqing,China,400014
2. Chongqing Key Laboratory of Child Infection and Immunity, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University,Chongqing,China,400014
Single-cell RNA sequencing in juvenile idiopathic arthritis
摘要
Abstract
Juvenile idiopathic arthritis (JIA) is one of the most common chronic inflammatory rheumatic diseases in children
with onset before age 16 and lasting for more than 6 weeks. JIA is a highly heterogeneous condition with various consequences for health and quality of life. For some JIA patients
early detection and intervention remain challenging. As a result
further investigation of the complex and unknown mechanisms underlying JIA is required. Advances in technology now allow us to describe the biological heterogeneity and function of individual cell populations in JIA. Through this review
we hope to provide novel ideas and potential targets for the diagnosis and treatment of JIA by summarizing the current findings of single-cell RNA sequencing studies and understanding how the major cell subsets drive JIA pathogenesis.
Integrated analysis on transcriptome and behaviors defines HTT repeat-dependent network modules in Huntington's disease
相关作者
Lulin Huang
Li Fang
Qian Liu
Abolfazl Doostparast Torshizi
Kai Wang
相关机构
The Key Laboratory for Human Disease Gene Study of Sichuan Province, Department of Clinical Laboratory, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China
Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia